Shares of Allergan (AMEX:AGN) traded today at $106.40, breaking its 52-week high. So far today approximately 1.7 million shares have been exchanged, as compared to an average 30-day volume of 1.5 million shares.
Allergan, Inc. is a multi-specialty health care company that discovers, develops and commercializes pharmaceuticals, biologics and medical devices. The Company develops products for the ophthalmic, neurological, medical aesthetics, medical dermatology, breast aesthetics, obesity intervention, urological and other specialty markets in countries around the world.
Allergan (AMEX:AGN) has potential upside of 1.5% based on a current price of $104.36 and analysts' consensus price target of $105.95. Allergan shares have support at the 50-day moving average (MA) of $94.33 and additional support at the 200-day MA of $91.43.
Allergan share prices have moved between a 52-week high of $106.40 and a 52-week low of $81.28 and are now trading 28% above that low price at $104.36 per share. Over the past week, the 200-day moving average (MA) has remained constant while the 50-day MA has advanced 0.6%.